Acasti Pharma Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Laval Canada (2002)
Status: No NME R&D (2002)

Organization Overview

First Clinical Trial
2011
NCT01455844
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Acasti Pharma Inc.